Inhibition of cell migration by ouabain in the A549 human lung cancer cell line

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 475-479

  Liu, Ning ^a   Li, Yali ^b   Su, Suwen ^a   Wang, Na ^a   Wang, Huici ^a   Li, Junxia ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

Cancer; Epithelial mesenchymal transition; Migration; Na+ K+ ATPase inhibitor; Ouabain

Indexed keywords

EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; NERVE CELL ADHESION MOLECULE; OUABAIN; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING; WOUND HEALING;

EID: 84879485299     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1406     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
3. Yin W, Cheng W, Shen W, et al: Impairment of Na(+), K(+)-ATPase in CD95(APO-1)induced human T-cell leukemia cell apoptosis mediated by glutathione depletion and generation of hydrogen peroxide. Leukemia 21: 1669-1678, 2007.
4. +ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells. Biochem Biophys Res Commun 375: 608-613, 2008.
5. Prassas I and Diamandis EP: Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 7: 926-935, 2008.
6. Haux J: Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses 53: 543-548, 1999.
7. Xu ZW, Wang FM, Gao MJ, et al: Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth. J Steroid Biochem Mol Biol 125: 181-191, 2011.
8. Klymkowsky MW and Savagner P: Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am JPathol 174: 1588-1593, 2009.
9. Peng CW, Liu XL, Liu X and Li Y: Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J Transl Med 8: 101, 2010.
10. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
11. Espinosa-Neira R, Mejia-Rangel J, Cortes-Reynosa P and SalazarEP: Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10A. Int J Biochem Cell Biol 43: 1782-1791, 2011.
12. Kim MA, Lee HS, Lee HE, Kim JH, Yang HK and KimWH: Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology 54: 442-451, 2009.
13. Joost S, Almada LL, Rohnalter V, et al: GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells. Cancer Res 72: 88-99, 2012.
14. Walker S: Updates in non-small cell lung cancer. Clin J Oncol Nurs 12: 587-596, 2008.
15. Shintani Y, Okimura A, Sato K, et al: Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg 92: 1794-1804, 2011.
16. Hardy KM, Booth BW, Hendrix MJC, Salomon DS and StrizziL: ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 15: 191-199, 2010.
17. Wu K and Bonavida B: The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29: 241-254, 2009.
18. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
19. Mariotti A, Perotti A, Sessa C and Rüegg C: N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs 16: 451-465, 2007.
20. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y and JohnsonKR: Cadherin switching. J Cell Sci 121: 727-735, 2008.
21. Kokkinos MI, Wafai R, Wong MK, Newgreen DF, ThompsonEW and Waltham M: Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs 185: 191-203, 2007.
22. Uddin MN, Horvat D, Glaser SS, et al: Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 29: 266-273, 2008.
23. Huang CY, Lin CY, Tsai CW and Yin MC: Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicol In Vitro 25: 1274-1280, 2011.
24. Hua H, Li M, Luo T, Yin Y and Jiang Y: Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci 68: 3853-3868, 2011.
25. Lin CY, Tsai PH, Kandaswami CC, et al: Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102: 815-827, 2011.